Table 2.
Gene | ROC AUC (95% CI) | ROC p-value | Sensitivity % (95% CI) | Specificity % (95% CI) | Cut-off |
---|---|---|---|---|---|
C1QA | 0.98 (0.95–1.02) | < 0.0001 | 88.24 (63.56–98.54) | 100 (66.37–100) | > 3.74 |
CD274 | 1.00 | < 0.0001 | 100 (80.49–100) | 100 (66.37–100) | > 5.71 |
CD59 | 0.98 (0.95–1.02) | < 0.0001 | 94.12 (71.31–99.85) | 100 (66.37–100) | > 8.63 |
CEACAM1 | 1.00 | < 0.0001 | 100 (80.49–100) | 100 (66.37–100) | > 6.02 |
CR1 | 1.00 | < 0.0001 | 100 (80.49–100) | 100 (66.37–100) | > 10.02 |
FCGR1A/B | 1.00 | < 0.0001 | 100 (80.49–100) | 100 (66.37–100) | > 7.83 |
ICAM1 | 0.98 (0.95–1.02) | < 0.0001 | 88.24 (63.56–98.54) | 100 (66.37–100) | > 7.54 |
IFITM1 | 1.00 | < 0.0001 | 100 (80.49–100) | 100 (66.37–100) | > 12.86 |
IL18RAP | 0.98 (0.95–1.02) | < 0.0001 | 88.24 (63.56–98.54) | 100 (66.37–100) | > 8.97 |
IL4R | 0.98 (0.95–1.02) | < 0.0001 | 94.12 (71.31–99.85) | 100 (66.37–100) | > 9.08 |
IRAK3 | 1.00 | < 0.0001 | 100 (80.49–100) | 100 (66.37–100) | > 6.86 |
JAK2 | 0.99 (0.97–1.01) | < 0.0001 | 94.12 (71.31–99.85) | 100 (66.37–100) | > 9.86 |
JAK3 | 0.99 (0.97–1.01) | < 0.0001 | 94.12 (71.31–99.85) | 100 (66.37–100) | > 8.59 |
LILRA5 | 0.97 (0.92–1.02) | < 0.0001 | 88.24 (63.56–98.54) | 100 (66.37–100) | > 9.87 |
LILRA6 | 1.00 | < 0.0001 | 100 (80.49–100) | 100 (66.37–100) | > 7.79 |
LY96 | 0.99 (0.97–1.01) | < 0.0001 | 94.12 (71.31–99.85) | 100 (66.37–100) | > 7.69 |
MAPK14 | 1.00 | 0.0008757 | 100 (80.49–100) | 100 (47.82–100) | > 10.03 |
NOD2 | 0.92 (0.81–1.04) | 0.004259 | 82.35 (56.57–96.20) | 100 (47.82–100) | > 8.79 |
PDCD1LG2 | 1.00 | 0.0008757 | 100 (80.49–100) | 100 (47.82–100) | > 4.13 |
PML | 0.98 (0.95–1.02) | 0.001156 | 94.12 (71.31–99.85) | 100 (47.82–100) | > 7.72 |
SOCS3 | 0.96 (0.88–1.04) | 0.001981 | 94.12 (71.31–99.85) | 100 (47.82–100) | > 7.40 |
TAP1 | 0.97 (0.92–1.03) | 0.001518 | 88.24 (63.56–98.54) | 100 (47.82–100) | > 8.63 |
TNFAIP6 | 0.98 (0.95–1.02) | 0.001156 | 94.12 (71.31–99.85) | 100 (47.82–100) | > 6.02 |